Live Cell Encapsulation Market
Request Sample Report
Live Cell Encapsulation Market Size and Growth
The Live Cell Encapsulation market is experiencing significant growth, driven by advancements in biotechnology and regenerative medicine. The market size is projected to reach approximately $1.2 billion by 2026, with a CAGR of around 12%. Increasing applications in drug delivery and tissue engineering are key factors contributing to this expansion.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ BioTime
◍ Reed Pacific
◍ Viacyte
◍ Neurotech
◍ Living Cell Technologies
◍ Merck KGAA
◍ Sigilon
◍ Encapsys
◍ Evonik
◍ Balchem
The live cell encapsulation market features companies like BioTime, Viacyte, and Merck KGAA, leveraging encapsulation for therapeutic applications. They enhance drug delivery and regenerative medicine, fostering market growth. Notable sales figures include:
- Merck KGaA: €23 billion (2022)
- BioTime: $10 million (2022)
- Balchem: $712 million (2022).
Request Sample Report
Market Segmentation
By Application By Product
Probiotics
Transplant
Drug Delivery
Research
Request Sample Report
Alginate
HEMA-MMA
Chitosan
Siliceous Encapsulates
Cellulose Sulfate
PAN-PVC
Other Polymers
$ 425.70 Million
Request Sample Report
